Enalapril in Hypertension and Congestive Heart Failure
Authors:
- R. O. DaviesRDR. O. Davies
- 1 January 1985
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 30 (Supplement) , 82-89
Abstract
Multiclinic controlled studies have shown that enalapril alone 10 to 40 mg/day orally is effective in lowering blood pressure in patients with essential hypertension. Enalapril has been compared with...Keywords
This publication has 16 references indexed in Scilit:
- Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.Circulation, 1984
- Enalapril in essential hypertension: a comparative study with propranolol. Enalapril in Hypertension Study Group (UK).British Journal of Clinical Pharmacology, 1984
- Review of the Overall Experience of Captopril in HypertensionArchives of internal medicine (1960), 1984
- Comparison of oral MK 421 and propranolol in mild to moderate essential hypertension and their effects on arterial and venous vessels of the forearmThe American Journal of Cardiology, 1984
- Enalapril (MK421) in the treatment of hypertension with renal artery stenosis.1983
- Evaluation of a long-acting converting enzyme inhibitor (Enalapril) for the treatment of chronic congestive heart failureJACC, 1983
- Factors related to first dose hypotensive effect of captopril: prediction and treatment.BMJ, 1983
- Effects of the New Oral Angiotensin Converting Enzyme Inhibitor MK-421 In Human HypertensionClinical and Experimental Hypertension. Part A: Theory and Practice, 1982
- Effect of Arterial Compliance on Systolic Blood Pressure and Cardiac FunctionClinical and Experimental Hypertension. Part A: Theory and Practice, 1982
- A new class of angiotensin-converting enzyme inhibitorsNature, 1980